Clara Montagut Viladot

Title: Clara Montagut Viladot: Innovator in Cancer Treatment

Introduction

Clara Montagut Viladot is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on identifying mutations in the epidermal growth factor receptor gene, which plays a crucial role in cancer therapy.

Latest Patents

Clara's latest patents include a method of treating cancer based on identifying mutations in the extracellular domain III of the epidermal growth factor receptor gene. This invention relates to newly identified mutations that lead to amino acid changes, which are highly correlated with resistance to a therapy regimen comprising cetuximab. The invention encompasses peptide sequences and primers to detect these mutations, as well as kits designed to predict a subject's response to therapy involving cetuximab. This method is particularly useful for treating metastatic colorectal cancer.

Another significant patent involves a newly identified mutation in the epidermal growth factor receptor gene, which also leads to an amino acid change. This mutation is associated with resistance to cetuximab and sensitivity to panitumumab. Similar to her other patent, this invention includes peptide sequences, primers, and probes for detecting the mutation, along with kits for predicting responses to therapy regimens involving cetuximab and/or panitumumab. This invention is applicable to metastatic colorectal cancer and head and neck cancer.

Career Highlights

Clara has worked with the Fundació Institut Mar d'Investigacions Médiques (IMIM), where she has contributed to groundbreaking research in cancer treatment. Her work has been instrumental in advancing the understanding of genetic mutations and their implications for therapy.

Collaborations

Clara has collaborated with notable professionals in her field, including Joan Albanell Mestres and Ana Rovira Guerin. These collaborations have further enriched her research and contributed to the development of her innovative patents.

Conclusion

Clara Montagut Viladot is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for more effective therapies. Her dedication to research and collaboration continues to impact the medical community positively.